company background image
TFX

TeleflexNYSE:TFX Stock Report

Last Price

US$325.75

Market Cap

US$15.3b

7D

2.9%

1Y

-16.1%

Updated

16 Jan, 2022

Data

Company Financials +
TFX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance4/6
Financial Health3/6
Dividends0/6

TFX Stock Overview

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.

Teleflex Competitors

Abbott Laboratories

NYSE:ABT

US$219.8b

Intuitive Surgical

NasdaqGS:ISRG

US$109.9b

Stryker

NYSE:SYK

US$100.6b

Edwards Lifesciences

NYSE:EW

US$73.8b

Price History & Performance

Summary of all time highs, changes and price drops for Teleflex
Historical stock prices
Current Share PriceUS$325.75
52 Week HighUS$449.38
52 Week LowUS$289.00
Beta1.11
1 Month Change1.32%
3 Month Change-9.48%
1 Year Change-16.12%
3 Year Change26.30%
5 Year Change96.95%
Change since IPO3,039.76%

Recent News & Updates

Jan 03
Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?

Today we're going to take a look at the well-established Teleflex Incorporated ( NYSE:TFX ). The company's stock saw a...

Dec 21
Is Teleflex (NYSE:TFX) A Risky Investment?

Is Teleflex (NYSE:TFX) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Dec 14

Teleflex Is Now Trading At Fair Value

About two years ago, I wrote a very bearish article on Teleflex due to a high valuation. Since that time, Teleflex stock has produced almost zero returns while the S&P 500 has returned over +60%. In this article, I revisit Teleflex stock to see where the valuation currently stands.

Shareholder Returns

TFXUS Medical EquipmentUS Market
7D2.9%-1.2%-0.5%
1Y-16.1%3.8%13.7%

Return vs Industry: TFX underperformed the US Medical Equipment industry which returned 3.8% over the past year.

Return vs Market: TFX underperformed the US Market which returned 13.7% over the past year.

Price Volatility

Is TFX's price volatile compared to industry and market?
TFX volatility
TFX Average Weekly Movement4.7%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.6%
10% most volatile stocks in US Market15.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: TFX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: TFX's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194314,000Liam Kellyhttps://www.teleflex.com

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.

Teleflex Fundamentals Summary

How do Teleflex's earnings and revenue compare to its market cap?
TFX fundamental statistics
Market CapUS$15.26b
Earnings (TTM)US$434.26m
Revenue (TTM)US$2.76b

35.1x

P/E Ratio

5.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
TFX income statement (TTM)
RevenueUS$2.76b
Cost of RevenueUS$1.25b
Gross ProfitUS$1.51b
ExpensesUS$1.08b
EarningsUS$434.26m

Last Reported Earnings

Sep 26, 2021

Next Earnings Date

n/a

Earnings per share (EPS)9.27
Gross Margin54.86%
Net Profit Margin15.74%
Debt/Equity Ratio56.3%

How did TFX perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

15%

Payout Ratio

Valuation

Is Teleflex undervalued compared to its fair value and its price relative to the market?

26.3%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: TFX ($325.75) is trading below our estimate of fair value ($441.91)

Significantly Below Fair Value: TFX is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: TFX is good value based on its PE Ratio (35.1x) compared to the US Medical Equipment industry average (47.8x).

PE vs Market: TFX is poor value based on its PE Ratio (35.1x) compared to the US market (17.4x).


Price to Earnings Growth Ratio

PEG Ratio: TFX is poor value based on its PEG Ratio (5.9x)


Price to Book Ratio

PB vs Industry: TFX is overvalued based on its PB Ratio (4.2x) compared to the US Medical Equipment industry average (3.5x).


Future Growth

How is Teleflex forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

5.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: TFX's forecast earnings growth (5.9% per year) is above the savings rate (2%).

Earnings vs Market: TFX's earnings (5.9% per year) are forecast to grow slower than the US market (13% per year).

High Growth Earnings: TFX's earnings are forecast to grow, but not significantly.

Revenue vs Market: TFX's revenue (5.8% per year) is forecast to grow slower than the US market (9.3% per year).

High Growth Revenue: TFX's revenue (5.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TFX's Return on Equity is forecast to be low in 3 years time (17.2%).


Past Performance

How has Teleflex performed over the past 5 years?

17.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TFX has high quality earnings.

Growing Profit Margin: TFX's current net profit margins (15.7%) are higher than last year (14.7%).


Past Earnings Growth Analysis

Earnings Trend: TFX's earnings have grown by 17.1% per year over the past 5 years.

Accelerating Growth: TFX's earnings growth over the past year (17.9%) exceeds its 5-year average (17.1% per year).

Earnings vs Industry: TFX earnings growth over the past year (17.9%) underperformed the Medical Equipment industry 51.2%.


Return on Equity

High ROE: TFX's Return on Equity (11.9%) is considered low.


Financial Health

How is Teleflex's financial position?


Financial Position Analysis

Short Term Liabilities: TFX's short term assets ($1.5B) exceed its short term liabilities ($562.2M).

Long Term Liabilities: TFX's short term assets ($1.5B) do not cover its long term liabilities ($2.8B).


Debt to Equity History and Analysis

Debt Level: TFX's net debt to equity ratio (42.5%) is considered high.

Reducing Debt: TFX's debt to equity ratio has increased from 47.6% to 56.3% over the past 5 years.

Debt Coverage: TFX's debt is well covered by operating cash flow (31.3%).

Interest Coverage: TFX's interest payments on its debt are well covered by EBIT (8.9x coverage).


Balance Sheet


Dividend

What is Teleflex current dividend yield, its reliability and sustainability?

0.42%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: TFX's dividend (0.42%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.32%).

High Dividend: TFX's dividend (0.42%) is low compared to the top 25% of dividend payers in the US market (3.44%).


Stability and Growth of Payments

Stable Dividend: TFX is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: TFX is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: TFX is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TFX's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.2yrs

Average management tenure


CEO

Liam Kelly (54 yo)

5.67yrs

Tenure

US$6,328,349

Compensation

Mr. Liam J. Kelly has been Chief Executive Officer at Teleflex Incorporated since January 01, 2018 and has been its Director since May 4, 2018. He serves as Director of Colfax Corporation since January 1,...


CEO Compensation Analysis

Compensation vs Market: Liam's total compensation ($USD6.33M) is below average for companies of similar size in the US market ($USD11.18M).

Compensation vs Earnings: Liam's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: TFX's management team is seasoned and experienced (5.2 years average tenure).


Board Members

Experienced Board: TFX's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: TFX insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Teleflex Incorporated's employee growth, exchange listings and data sources


Key Information

  • Name: Teleflex Incorporated
  • Ticker: TFX
  • Exchange: NYSE
  • Founded: 1943
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$15.260b
  • Shares outstanding: 46.84m
  • Website: https://www.teleflex.com

Number of Employees


Location

  • Teleflex Incorporated
  • 550 East Swedesford Road
  • Suite 400
  • Wayne
  • Pennsylvania
  • 19087-1603
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/16 23:25
End of Day Share Price2022/01/14 00:00
Earnings2021/09/26
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.